The development of national guidelines for pain control: synopsis and commentary.
This synopsis outlines factors that prompted development of national clinical practice guidelines for the management of pain and presents the essential content of major pain control guidelines. Also described is the concurrent growth of the evidence-based pain management movement worldwide in the decade since initial US federal guidelines on acute and cancer pain were developed, and products of this global movement. The latter include systematic reviews and meta-analyses about treatments for pain, their assemblage in resources such as the Cochrane Collaboration, and (in the US) the embedding of pain assessment and management within quality assurance requirements for hospital accreditation. This survey will highlight recent research that evidence-based guidelines alone are insufficient to overcome established attitudes, practices and myths that hinder pain assessment and management. Hypotheses for the inadequacy of scientific evidence per se to overcome clinicians' attitudes and practices will be advanced, along with suggestions as to how those in the 'pain treatment community' may help to tip the balance.
Carr
D B
DB
Tufts University School of Medicine, New England Medical Center, Boston, MA 02111, USA. dcarr02@emerald.tufts.edu.
D000700:Analgesics / Q000627:therapeutic use*; D006291:Health Policy; D006801:Humans; D010146:Pain / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D014481:United States
D000700:Analgesics